Syngene International and HiMedia Laboratories, which have collaborated to manufacture ELISafe 19, an IgG based ELISA test kit for Covid-19, have received the approval by the Indian Council of Medical Research (ICMR). The product will be launched once it receives approval from the Central Drugs Standard Control Organisation (CDSCO) next.
The test kits, developed indigenously by Biocon’s research arm Syngene, test the presence of SARS-COV-2 antibodies which confirm that a patient has been exposed to the coronavirus. It has a capacity to test samples together in a single run and generates results within three hours.
ALSO READ: In